Resistant Hypertension remains one of the most under-recognized yet high-risk phenotypes in cardiovascular medicine.

Nearly 1 in 5 treated patients meet criteria for apparent resistance—and up to half may reflect nonadherence or white-coat effect.

This concise visual series distills key insights from a recent JAMA review on diagnosis, pathophysiology, and stepwise management—including the pivotal role of spironolactone and emerging therapies like renal denervation.

Precision begins with correct classification. Treatment begins with clarity. 💡

#Hypertension #Cardiology #PrecisionMedicine #JAMA